Immune interception in cancer: prioritizing vaccination in high-risk and premalignant settings - Quiz - MDSpire

Immune interception in cancer: prioritizing vaccination in high-risk and premalignant settings

  • By

  • Quanbin Zhang

  • Le Wang

  • Liping Ze

  • Tao Wei

  • Wenpeng Zhang

  • May 15, 2026

  • 0 min

Share

Original Source(s)

Immune interception in cancer: prioritizing vaccination in high-risk and premalignant settings

  • by Quanbin Zhang, Le Wang, Liping Ze, Tao Wei, Wenpeng Zhang

  • May 15, 2026

Related Content

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms